NEW YORK (GenomeWeb News) – Ohio State University will partner with the Coriell Institute for Medical Research in a personalized medicine study that will enroll 2,000 participants from OSU Medical Center.

OSU said today that it has joined Coriell Personalized Medicine Collaborative, which involves four other participating centers, including Fox Chase Cancer Center, Cooper University Hospital, Virtua Health, and Helix Health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.